Atlas Trials

Therapeutic HPV-16 Vaccination for the Treatment of Anal Dysplasia

Clinical trial NCT01923116 · COMPLETED

Trial details

NCT number
NCT01923116
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Anal Intraepithelial NeoplasiaHIV
Start date
2013-08-01
Primary completion
2017-06-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.